ALEJANDRO A DACANAY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHANDLER, AZ NPI 1770194243
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AZ NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$5,758.23
- Category: General Payments
- Program years: PY2021–2024
- Record count: 268
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,499.08 across 64 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,499.08 | 64 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $211.87 | 9 |
| Daiichi Sankyo Inc. | $188.53 | 8 |
| GENZYME CORPORATION | $113.14 | 4 |
| SpringWorks Therapeutics, Inc. | $109.07 | 5 |
| Acerta Pharma LLC | $94.65 | 4 |
| Merck Sharp & Dohme Corporation | $74.51 | 3 |
| TerSera Therapeutics LLC | $65.58 | 2 |
| GlaxoSmithKline, LLC. | $63.72 | 3 |
| ARRAY BIOPHARMA INC | $63.61 | 3 |
| SOBI, INC | $60.07 | 3 |
| Rigel Pharmaceuticals, Inc. | $53.75 | 2 |
| ABBVIE INC. | $50.57 | 3 |
| Ipsen Biopharmaceuticals, Inc | $45.75 | 2 |
| Regeneron Healthcare Solutions, Inc. | $39.37 | 1 |
| Gilead Sciences, Inc. | $39.00 | 2 |
| PFIZER INC. | $38.32 | 2 |
| EISAI INC. | $30.26 | 1 |
| Genentech USA, Inc. | $29.71 | 1 |
| Astellas Pharma US Inc | $25.80 | 1 |
| Deciphera Pharmaceuticals Inc. | $22.19 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.21 | 1 |
| Lilly USA, LLC | $20.87 | 1 |
| Celgene Corporation | $19.36 | 1 |
| Tempus AI, Inc | $18.17 | 1 |
By program year
Records — PY2024 (64)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.